Search Results

Press Releases

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

April 2, 2025

·

2 min read

Press Releases

Celcuity to Participate at Upcoming Cowen and Leerink Investor Conferences

February 26, 2025

·

1 min read

Press Releases

Celcuity Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

April 1, 2025

·

14 min read

Press Releases

Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2024 Financial Results and Webcast/Conference Call

March 25, 2025

·

2 min read

BioMidwest

Celcuity To Participate in Jefferies Global Healthcare Conference

Celcuity Inc. today announced its participation in the Jefferies Global Healthcare Conference to be held in New York on June 4-6, 2024.

June 3, 2024

·

1 min read

Deals

Celcuity Announces Pricing of Underwritten Common Stock Offering

Celcuity Inc. today announced the pricing of an underwritten offering of 3,871,000 shares of its common stock at an offering price of $15.50 per share.

May 30, 2024

·

5 min read

BioMidwest

Celcuity To Present at Upcoming Needham and Stifel Investor Conferences

Celcuity Inc. announced that Brian Sullivan, Chief Executive Officer, and Co-founder of Celcuity, will present and be available for one-on-one investor meetings at the following investor conferences:

April 4, 2024

·

2 min read

Press Releases

Celcuity Inc. Reports Third Quarter Financial Results and Provides Corporate Update

November 14, 2024

·

13 min read

Business

Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced financial results for the first quarter ended March 31, 2024 and other recent business developments.

May 15, 2024

·

11 min read

Press Releases

Celcuity Inc. Schedules Release of Third Quarter 2024 Financial Results and Webcast/Conference Call

November 8, 2024

·

2 min read